Nc1ccn([C@@H]2O[C@H](COC(=O)[C@]34C[C@@H]5C[C@H](C[C@@H](C5)C3)C4)[C@@H](O)[C@@H]2O)c(=O)n1
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?